ProfileGDS4132 / 242208_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 30% 32% 27% 21% 24% 33% 28% 26% 24% 23% 32% 27% 27% 29% 23% 24% 30% 28% 24% 30% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10173.738230
GSM201543Muscle PCOS pioglitazone 12171.341632
GSM201544Muscle PCOS pioglitazone 16167.621827
GSM201545Muscle PCOS pioglitazone 20154.001721
GSM201829Muscle PCOS pioglitazone 23158.831124
GSM201830Muscle PCOS pioglitazon 25186.671333
GSM201831Muscle PCOS pioglitazone 27166.723528
GSM201832Muscle PCOS pioglitazone 3164.564726
GSM201833Muscle PCOS pioglitazone 4153.530324
GSM201834Muscle PCOS pioglitazone 8149.023223
GSM201835Muscle PCOS after pioglitazone 10266.842732
GSM201836Muscle PCOS after pioglitazone 12255.102127
GSM201837Muscle PCOS after pioglitazone 16251.462927
GSM201838Muscle PCOS after pioglitazone 20262.104829
GSM201839Muscle PCOS after pioglitazone 23247.750223
GSM201840Muscle PCOS after pioglitazone 25253.806624
GSM201841Muscle PCOS after pioglitazone 27258.640530
GSM201842Muscle PCOS after pioglitazone 3254.608928
GSM201843Muscle PCOS after pioglitazone 4255.474124
GSM201844Muscle PCOS after pioglitazone 8269.341730